Your browser doesn't support javascript.
loading
Transvenous Radiofrequency Catheter Ablation for an Aldosterone-Producing Tumor of the Left Adrenal Gland: A First in Human Case Report.
Oguro, Sota; Ota, Hideki; Yanagaki, Satoru; Kawabata, Masahiro; Kamada, Hiroki; Omata, Kei; Tezuka, Yuta; Ono, Yoshikiyo; Morimoto, Ryo; Satoh, Fumitoshi; Toyama, Hiroaki; Tanimoto, Kouta; Konno, Daisuke; Yamauchi, Masanori; Niwa, Yuki; Miyamoto, Hisao; Mori, Kenji; Tanaka, Tetsuhiro; Ishihata, Hiroshi; Takase, Kei.
Afiliación
  • Oguro S; Diagnostic Radiology, Tohoku University Graduate School of Medicine, 2-1 Seiryo-Machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.
  • Ota H; Diagnostic Radiology, Tohoku University Graduate School of Medicine, 2-1 Seiryo-Machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.
  • Yanagaki S; Diagnostic Radiology, Tohoku University Graduate School of Medicine, 2-1 Seiryo-Machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.
  • Kawabata M; Diagnostic Radiology, Tohoku University Graduate School of Medicine, 2-1 Seiryo-Machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.
  • Kamada H; Diagnostic Radiology, Tohoku University Graduate School of Medicine, 2-1 Seiryo-Machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.
  • Omata K; Department of Diabetes, Metabolism and Endocrinology, Tohoku University Hospital, Sendai, Miyagi, Japan.
  • Tezuka Y; Division of Nephrology, Rheumatology, and Endocrinology, Tohoku University, Sendai, Miyagi, Japan.
  • Ono Y; Department of Diabetes, Metabolism and Endocrinology, Tohoku University Hospital, Sendai, Miyagi, Japan.
  • Morimoto R; Division of Nephrology, Rheumatology, and Endocrinology, Tohoku University, Sendai, Miyagi, Japan.
  • Satoh F; Department of Diabetes, Metabolism and Endocrinology, Tohoku University Hospital, Sendai, Miyagi, Japan.
  • Toyama H; Division of Nephrology, Rheumatology, and Endocrinology, Tohoku University, Sendai, Miyagi, Japan.
  • Tanimoto K; Division of Nephrology, Rheumatology, and Endocrinology, Tohoku University, Sendai, Miyagi, Japan.
  • Konno D; Division of Nephrology, Rheumatology, and Endocrinology, Tohoku University, Sendai, Miyagi, Japan.
  • Yamauchi M; Department of Anesthesiology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
  • Niwa Y; Department of Anesthesiology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
  • Miyamoto H; Department of Anesthesiology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
  • Mori K; Department of Anesthesiology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
  • Tanaka T; Research & Development Department, Japan Lifeline Co., Ltd., Saitama, Japan.
  • Ishihata H; Research & Development Department, Japan Lifeline Co., Ltd., Saitama, Japan.
  • Takase K; Research & Development Department, Japan Lifeline Co., Ltd., Saitama, Japan.
Cardiovasc Intervent Radiol ; 46(12): 1666-1673, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37973663
PURPOSE: To describe a novel technique of transvenous radiofrequency catheter ablation of an aldosterone-producing adenoma (APA) of the left adrenal gland using the GOS System (Japan Lifeline, Tokyo, Japan). Using the GOS system, a flexible radiofrequency tip catheter can be inserted into the adrenal central and tributary veins, the drainers for functional tumors. MATERIALS AND METHODS: An APA at the left adrenal gland, which was diagnosed by segmental adrenal venous sampling following administration of 0.25 mg cosyntropin, was ablated using the GOS catheter inserted into adrenal tributary veins via a right femoral vein 7-Fr sheath. The effect of radiofrequency ablation on APA was assessed using the international consensus on surgical outcomes for unilateral primary aldosteronism (PA). RESULTS: No device-related complications were observed. The patient was deeply sedated under blood pressure and heart rate control with continuous administration of ß-blockers. Then, the tumor and surrounding adrenal gland were cauterized at 7000 J two times each in sequence. The output time was 7-11 min for each ablation and 80 min in total. For blood pressure and pulse rate control, esmolol hydrochloride and phentolamine mesylate were used. The contrast enhancement of APA disappeared on dynamic CT immediately after the procedure. PA was biochemically cured until 12 months after the procedure. CONCLUSION: Using the radiofrequency device with the GOS catheter and system is a method for cauterizing adrenal tumors from blood vessels. This approach resulted in a marked reduction in aldosterone concentrations and a complete biochemical cure of PA over the observation period.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ablación por Catéter / Neoplasias de las Glándulas Suprarrenales / Hiperaldosteronismo Límite: Humans Idioma: En Revista: Cardiovasc Intervent Radiol Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ablación por Catéter / Neoplasias de las Glándulas Suprarrenales / Hiperaldosteronismo Límite: Humans Idioma: En Revista: Cardiovasc Intervent Radiol Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos